iShares U.S. Healthcare ETF (IYH)

  • Loading...

Best Fit Health/Biotechnology Funds ETFs

U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 14 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.

How we identify Best Fit Funds

Best Fit Scorecard
Costs Good
Tracking Error Excellent
Bid/Ask Ratio Typical
Holdings Diversity Good

Fund Description

The investment seeks to track the investment results of an index composed of U.S. equities in the healthcare sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Health Care Index (the "underlying index"), which measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.

Fund Snapshot Updated 07.22.2014

Previous Close $129.60 Expense Ratio 0.48%
YTD Return 11.87% Avg. 30-Day Volume 331,155
1-Year Return 22.8% Market Cap Loading...
Bid $129.53 Shares Outstanding 19,000,000
Ask $129.57 Dividends $1.39
Top 10 Holdings
Johnson & Johnson (JNJ) 11.58%
Pfizer Inc (PFE) 7.77%
Merck & Co Inc New (MRK) 6.82%
Gilead Sciences Inc (GILD) 5.48%
Amgen Inc (AMGN) 3.66%
Abbvie Inc (ABBV) 3.43%
Unitedhealth Group Inc (UNH) 3.37%
Bristol Myers Squibb Co (BMY) 3.25%
Biogen Idec Inc (BIIB) 2.88%
Celgene Corp (CELG) 2.77%
% of Total Holdings 51.00%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds